Stimulation of RA monocytes with the synthetic TLR2 agonist, LTA, induced an increase of IL-6, IL-1β and TNFα expression in CD14++ CD16− subsets when compared to healthy donors (Fig. 5a). The gene discussed is CD14; the disease is rheumatoid arthritis.